期刊文献+

慢性胰腺炎并发糖尿病患者的循证治疗 被引量:12

Evidence-Based Treatment for Chronic Pancreatitis Patient with New Onset Diabetes
下载PDF
导出
摘要 目的针对慢性胰腺炎随访中新发糖尿病的患者,展开最佳治疗证据的检索,指导胰源性糖尿病的治疗。方法计算机检索MEDLINE、EMBASE、Cochrane图书馆、CBMdisc、万方数据库和中国知网数据库,寻找胰源性糖尿病的治疗指南、系统评价、临床研究、文献综述等证据,并对所获证据进行分析评价。结果目前尚无胰源性糖尿病的诊治指南,胰源性糖尿病的治疗目标与其他类型糖尿病一致,治疗方法包括基础营养治疗、口服降糖药物和强化胰岛素治疗。降糖药物与胰岛素运用上存在一定分歧,强化胰岛素可能增加了发生胰腺癌的风险,而二甲双胍降低了这种可能性。结论胰源性糖尿病的治疗需采取综合措施,强调患者对血糖监测的依从性,避免严重低血糖的发生,同时做好早期胰腺肿瘤的检测。 Objective To formulate an individualized evidence-based treatment for a chronic pancreatitis patient with new onset diabetes. Methods We attempted to get the evidences of treatments in pancreatic diabetes, which induced by chronic pancreatitis, by searching MEDLINE, EMBASE, Cochrane library, CBM disc, Wanfang data and CNKI. The evidences were collected and critically assessed after the clinical issues were put forward. Results No clinical guideline was available for the treatment of pancreatic diabetes. With the same purpose of treatment in other types of diabetes, treatments of pancreatic diabetes included basic nutrition therapy, oral agencies for blood glucose control and intensive insulin therapy. Discussions of the use of antidiabetic drugs and insulin were ongoing, and different opinions were detected. Insulin might increase the risk of pancreatic cancer, while metformin reduced this possibility. Conclusion Comprehensive measures should be taken in the management of pancreatic diabetes. Intensive insulin therapy should be applied to patients with high compliance, and avoid the occurrence of severe hypoglycemia. Meanwhile, early tumor detection should be especially noticed with pancreatic diabetes.
出处 《循证医学》 CSCD 2013年第5期281-284,291,共5页 The Journal of Evidence-Based Medicine
关键词 胰源性糖尿病 胰腺肿瘤 血糖 并发症 循证治疗 pancreatic diabetes pancreatic tumor blood glucose complication evidence-based treatment
  • 相关文献

参考文献26

  • 1王兴鹏,徐肇敏,许国铭.慢性胰腺炎诊治指南(2005年,南京)[J].中华消化杂志,2005,25(5):319-320. 被引量:14
  • 2袁耀宗,李为光.重视糖尿病与胰腺癌内在关系的研究,降低胰腺癌的发病率![J].胃肠病学,2010,15(2):65-67. 被引量:3
  • 3American Diabetes Association. Diagnosis and classification of diabetes mellitus [J]. Diabetes Care, 2010,33 (Suppl 1): S62-S69. 被引量:1
  • 4中华医学会糖尿病学分会.中国2型糖尿病防治指南:2010年版[M].北京:北京大学医学出版社,2011. 被引量:2
  • 5Cui Y, Andersen DK. Pancreatogenic diabetes: Special considerations for management [ J ]. Pancreatology, 2011,11 ( 3 ) : 279-294. 被引量:1
  • 6Andersen DK. The practical importance of recognizing pancreatogenic or type 3c diabetes [Jl. Diabetes Metab Res Rev, 2012,28 (4) : 326-328. 被引量:1
  • 7Andren-Sandberg A, Hardt PD. Second Giessen international workshop on interactions of exocrine and endocrine pancreatic diseases. Castle of Rauischholzhausen of the justus-liebig- university, Giessen (Rauischholzhansen), Germany. March 7- 8, 2008 [J]. JOP, 2008,9(4):541-575. 被引量:1
  • 8Linde J, Nilsson LH, Barany FR. Diabetes and hypoglycemia in chronic pancreatitis [J]. Scand J Gastroenterol, 1977,12 (3) : 369-373. 被引量:1
  • 9Lankisch PG, Lohr-Happe A, Otto J, et al. Natural course in chronic pancreatitis. Pain, exocrine and endocrine pancreatic insufficiency and prognosis of the disease [J]. Digestion, 1993,54(3) : 148-155. 被引量:1
  • 10Wakasugi H, Funakoshi A, Iguchi H. Clinical assessment of pancreatic diabetes caused by chronic pancreatitis [J]. J Gastroenterol, 1998,33(2):254-259. 被引量:1

二级参考文献108

  • 1Hardt PD, Brendel MD, Kloer HU, et al. ls pancreatic diabetes (type 3c diabetes) underdiagnosed and misdiagnosed? Diabetes Care ,2008,2 : S165-169. 被引量:1
  • 2Bank S, Marks IN, Vinik AI. Clinical and hormonal aspects of pancreatic diabetes. Am J Gastroenterol, 1975,64 : 13-22. 被引量:1
  • 3Schrader H,Menge BA, Schneider S, et al. Reduced Pancreatic Volume and beta-cell area in patients with chronic pancreatitis. Gastroenterology ,2009,136:513-522. 被引量:1
  • 4Goto M, Nakano I, Kimura T, et al. New chronic pancreatitis model with diabetes induced by cerulein plus stress in rats. Dig Dis Sci, 1995,40:2356-2363. 被引量:1
  • 5Cavallini G, Vaona B,Bovo P,et al. Diabetes in chronic alcoholic pancreatitis. Role of residual beta cell function and insulin resistance. Dig Dis Sci, 1993,38:497-501. 被引量:1
  • 6Nathan JD, Zdankiewicz PD, Wang J, et al. Impaired hepatocyte glucose transport protein (GLUT2) internalization in chronic panereatitis. Pancreas,2001,22:172-178. 被引量:1
  • 7Andersen DK. Mechanisms and emerging treatments of the metabolic complications of chronic pancreatitis. Pancreas,2007, 35:1-15. 被引量:1
  • 8Bluth M, Mueller CM, Pierre J, et al. Pancreatic regenerating protein Ⅰ in chronic pancreatitis and aging: implications for new therapeutic approaches to diabetes. Pancreas,2008 ,37 :386-395. 被引量:1
  • 9Hennig R, Kekis PB, Friess H, et al. Pancreatic polypeptide in pancreatitis ,2002,23:331-338. 被引量:1
  • 10Maartense S, Ledeboer M, Masclee AA. Chronic pancreatitis: relation between function and morphology. Dig Liver Dis, 2004, 36:61-67. 被引量:1

共引文献132

同被引文献79

  • 1吴丹,邱秋,唐亮,刘凯军,陈东风.2009年至2018年我国自身免疫性胰腺炎患者临床特征分析[J].中华胰腺病杂志,2020,20(5):368-372. 被引量:4
  • 2孙贺营.肝源性糖尿病中医病机论治探源[J].中国医药指南,2008,6(23):295-297. 被引量:7
  • 3王霞,赵昱.仝小林教授论继发性糖尿病的中医治疗[J].中医药学刊,2005,23(10):1764-1765. 被引量:14
  • 4Kwak MS ,Jang ES ,Ryu JK, et al. Risk factors of post en- doscopic retrograde cholangiopancreatography bacteremia [J]. Gut and Liver, 2013,7 (2) : 228. 被引量:1
  • 5Andriulli A, Loperfido S, Napolitano G, et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies[J]. Am J Gastroenterol, 2007, 102 ( 8 ) : 1 781. 被引量:1
  • 6ASGE Standards of Practice Committee, Khashab MA, Chithadi KV, et al.Antibiotic prophylaxis for GI endosco- py[J].Gastrointest Enclose, 2014, doi: 10.1016/j.gie. 2014. 08.008. 被引量:1
  • 7ASGE Standards of practice committee, Anderson MA, Fisher L, et aLComplications of ERCP[J]. Gastrointest Endosc,2012, 75(3) :467. 被引量:1
  • 8Byl B, Deviere J, Struelens M J, et al. Antibiotic prophy-laxis for infectious complications after therapeutic endo- scopic retrograde cholangiopancreatography: a random- ized, double-blind, placebo-controlled study[J]. Clin ln- fectDis, 1995,20(5) : 1 236. 被引量:1
  • 9Szary NM, Al-Kawas FH. Complications of endoscopic retrograde cholangiopancreatography: how to avoid and manage them[J]. Gastroenterol Hepatol: NY, 2013,9 (8) : 496. 被引量:1
  • 10Du B, Long Y, Liu H, et al. Extended-spectrum beta-lac- tamase-producing Escherichia coli and Klebsiella pneu- moniae bloodstream infection: risk factors and clinical outcome [J]. Intensive Care Med, 2002,28 ( 12 ) : 1 718. 被引量:1

引证文献12

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部